← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
26	ATHX 26 DELISTED Athersys, Inc. Common Stock ATHX	97	+16	+20%	$51M
27	NVTA 27 DELISTED Invitae Corporation NVTA	94	+17	+22%	$322M
28	NSTG 28 DELISTED NanoString Technologies, Inc. NSTG	92	+4	+5%	$383M
29	29 Regenxbio RGNX $454M	89	+3	+3%	$705M
30	BLCM 30 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	88	+4	+5%	$212M
31	31 Veracyte VCYT $3.5B	87	-1	-1%	$207M
32	32 Intellia Therapeutics NTLA $1.6B	85	0	0%	$439M
33	33 Atara Biotherapeutics ATRA $96M	82	-3	-4%	$441M
34	34 Standard BioTools LAB $248M	80	0	0%	$182M
35	35 Abeona Therapeutics ABEO $249M	75	+5	+7%	$335M
36	36 Voyager Therapeutics VYGR $124M	75	+23	+44%	$233M
37	37 Fate Therapeutics FATE $232M	74	+14	+23%	$101M
38	38 Lakefront Biotherapeutics American Depositary Shares LKFT $1.93B	69	-9	-12%	$1.03B
39	ADAP 39 DELISTED Adaptimmune Therapeutics ADAP	67	+11	+20%	$416M
40	AGTC 40 DELISTED Applied Genetic Technologies Corporation AGTC	67	-10	-13%	$33.6M
41	ISEE 41 DELISTED IVERIC bio, Inc. Common Stock ISEE	67	-10	-13%	$63.5M
42	42 CRISPR Therapeutics CRSP $4.86B	64	+25	+64%	$180M
43	43 Invesco Biotechnology & Genome ETF PBE $421M	60	-4	-6%	$55M
44	44 DELISTED Adverum Biotechnologies ADVM	58	-5	-8%	$49.5M
45	45 Fortress Biotech FBIO $63.4M	58	+4	+7%	$27M
46	46 Wave Life Sciences WVE $609M	58	+2	+4%	$446M
47	47 Arrowhead Research ARWR $8.25B	55	-4	-7%	$64.9M
48	48 Arbutus Biopharma ABUS $830M	53	+3	+6%	$207M
49	49 Cartesian Therapeutics RNAC $192M	53	+5	+10%	$222M
50	50 Neurogene NGNE $444M	43	+3	+8%	$300M